Analyses of adverse events and patient-reported outcomes with the toxicity index in cancer clinical trials

By afschroeder • October 23, 2025

Gresham G, Henry NL, Bandos H, Calsavara VF, Cecchini RS, Diniz MA, Hays RD, Luu M, Kim S, Rogatko A, Yothers G, Ganz PA, Tighiouart M. Analyses of adverse events and patient-reported outcomes with the toxicity index in cancer clinical trials. Cancer. 2025 Oct 15;131 Suppl 2:e70086. doi: 10.1002/cncr.70086. PMID: 41123586.

Tags: biostatistics, cancer clinical trials, Cedars Sinai DoM, General Internal Medicine, Hematology/Oncology, patient‐reported outcomes, Publications, toxicity, toxicity index, Treatment tolerability

What a pain in the back: etiology, diagnosis and future treatment directions for discogenic low back pain

Kaneda G, Zila L, Wechsler JT, Shafi K, Cheema K, Bae H, Kim SD, Tuchman A, Li D, Sheyn D. What a pain in the[...]

Oxidative stress-regulatory role of miR-10b-5p in the diabetic human cornea revealed through integrated multi-omics analysis

Zha D, Gamez J, Ebrahimi SM, Wang Y, Verma N, Poe AJ, White S, Shah R, Kramerov AA, Sawant OB, Santiskulvong C, Stotland AB, Wang[...]

Elevated co-expression of TIMM17A and NMT1 is associated with poor survival in non-small cell lung cancer

Chan AA, Sankar K, Reckamp KL, Díaz B, Lee DJ. Elevated co-expression of TIMM17A and NMT1 is associated with poor survival in non-small cell lung[...]